Last reviewed · How we verify
Tyvaso®
Tyvaso® is a Small molecule drug developed by Insmed Incorporated. It is currently FDA-approved. Also known as: Inhaled treprostinil.
Tyvaso is a small molecule drug that acts as a prostanoid IP receptor agonist. It is used to treat conditions such as Pulmonary Arterial Hypertension, and is administered via subcutaneous injection.
At a glance
| Generic name | Tyvaso® |
|---|---|
| Also known as | Inhaled treprostinil |
| Sponsor | Insmed Incorporated |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Inhaled Treprostinil in Sarcoidosis Patients With Pulmonary Hypertension (PHASE2)
- A Study to Observe the Safety, Tolerability, and Efficacy of Remodulin
- ADAPT - A Patient Registry of the Real-world Use of Orenitram®
- A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants (PHASE1)
- TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH) (PHASE4)
- Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH (PHASE4)
- Rapid Switch From Flolan to Remodulin in the Outpatient Clinic (PHASE4)
- Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tyvaso® CI brief — competitive landscape report
- Tyvaso® updates RSS · CI watch RSS
- Insmed Incorporated portfolio CI
Frequently asked questions about Tyvaso®
What is Tyvaso®?
Who makes Tyvaso®?
Is Tyvaso® also known as anything else?
What development phase is Tyvaso® in?
Related
- Manufacturer: Insmed Incorporated — full pipeline
- Also known as: Inhaled treprostinil
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing